DA-1241 clinical trials
Also written DA-1241.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How each study uses DA-1241 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- DA-1241
- 3
Studies by the year they started
3 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Dong-A ST Co., Ltd. (2) · NeuroBo Pharmaceuticals Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses DA-1241 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASHCompletedPhase 2NeuroBo Pharmaceuticals Inc.NCT06054815Written as DA-1241
- A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DMCompletedPhase 1Dong-A ST Co., Ltd.NCT03646721Written as DA-1241
- A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male SubjectsCompletedPhase 1Dong-A ST Co., Ltd.NCT03061981Written as DA-1241
Codes
What other systems call DA-1241 · ClinicalTrials.gg INT001841
- UNII (FDA) 6380I4YM3QVANOGLIPELConfirmed FDA, Wikidata
- Wikidata Q123857960DA-1241Confirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 6380I4YM3Q | VANOGLIPEL | Confirmed FDA, Wikidata |
| Wikidata | Q123857960 | DA-1241 | Confirmed FDA, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.